5hmC enhances PARP trapping and restores PARP inhibitor sensitivity in chemoresistant BRCA1/2-deficient cells
Journal of Biological Chemistry · 2025-07 · 301 (7) · 110393
DOI: 10.1016/j.jbc.2025.110393 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Biological Chemistry, 2025-07. Verfasst von Suhas S Kharat und 6 weiteren Autor:innen. Beteiligte Einrichtung: Mouse Cancer Genetics Program, Center for Cancer Research, National Cancer Institute, Frederick, Maryland, USA; Department of Biochemistry and Center…. Hauptthemen laut MEDLINE: Poly(ADP-ribose) Polymerase Inhibitors, BRCA1 Protein, Drug Resistance, Neoplasm, BRCA2 Protein. Die Arbeit wurde bisher 7-mal zitiert (Crossref) und nennt 85 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: NCI NIH HHS, National Institutes of Health National Cancer Institute, NIH.
Abstract (Originalsprache)
Mutations in BRCA1 and BRCA2 genes are the leading cause of hereditary breast and ovarian cancer. BRCA1/2-mutant cells are defective in repairing damaged DNA by homologous recombination and are characterized by hypersensitivity to PARP inhibitors. PARP inhibitors can trap PARP proteins on the chromatin, a mechanism that can contribute to the death of BRCA1/2-deficient cells. The FDA has approved multiple PARP inhibitors for the treatment of metastatic breast and ovarian cancers, yet despite the success of PARP inhibitors in treating BRCA1/2-mutant cancers, drug resistance is a major challenge. Here, we report that 5hmC enhances PARP1 trapping on the chromatin in olaparib-treated cells. Elevated PARP trapping generates replication gaps, leading to the restoration of PARP inhibitor sensitivity in chemoresistant BRCA1/2-deficient cells. Our findings suggest that combining 5hmC with olaparib can restore the sensitivity of chemoresistant BRCA1/2-deficient cells.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Mouse Cancer Genetics Program, Center for Cancer Research, National Cancer Institute, Frederick, Maryland, USA; Department of Biochemistry and Center for Structural Biology, Vanderbilt University, Nashville, Tennessee,…
- Mouse Cancer Genetics Program, Center for Cancer Research, National Cancer Institute, Frederick, Maryland, USA.
- Leidos Biomedical Research, Inc, Frederick National Laboratory for Cancer Research, Frederick, Maryland, USA.
- Department of Biochemistry and Center for Structural Biology, Vanderbilt University, Nashville, Tennessee, USA.
- Mouse Cancer Genetics Program, Center for Cancer Research, National Cancer Institute, Frederick, Maryland, USA. Electronic address: sharans@mail.nih.gov.
Förderung
- NCI NIH HHS
- National Institutes of Health National Cancer Institute
- NIH
Zitieren
APA
Kharat, S. S., Mishra, A. P., Sengodan, S. K., Dierman, D., Fox, S. D., Chazin, W. J., & Sharan, S. K. (2025). 5hmC enhances PARP trapping and restores PARP inhibitor sensitivity in chemoresistant BRCA1/2-deficient cells. Journal of Biological Chemistry, 301(7), 110393. https://doi.org/10.1016/j.jbc.2025.110393
Vancouver
Kharat SS, Mishra AP, Sengodan SK, Dierman D, Fox SD, Chazin WJ, et al. 5hmC enhances PARP trapping and restores PARP inhibitor sensitivity in chemoresistant BRCA1/2-deficient cells. Journal of Biological Chemistry. 2025;301(7):110393. doi:10.1016/j.jbc.2025.110393
BibTeX
@article{Kharat2025,
author = {Kharat, Suhas S and Mishra, Arun P and Sengodan, Satheesh K and Dierman, Dillon and Fox, Stephen D and Chazin, Walter J and Sharan, Shyam K},
title = {5hmC enhances PARP trapping and restores PARP inhibitor sensitivity in chemoresistant BRCA1/2-deficient cells},
journal = {Journal of Biological Chemistry},
year = {2025},
volume = {301},
number = {7},
pages = {110393},
doi = {10.1016/j.jbc.2025.110393}
}
EUVIMED